Tri Locum Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-47,604
Closed -$2.87M 34
2023
Q4
$2.87M Sell
47,604
-5,696
-11% -$344K 1.31% 22
2023
Q3
$3.04M Buy
+53,300
New +$3.04M 0.97% 30